The risk is small, according to a new study published by JAMA
In the fight against obesity and weight loss, such drugs as Saxenda and Mounjaro take on the focus of attracting consumers as the most effective products that can lose a lot of weight
Gutin left that table to join another regular who said the same thing
Yes, persistent or worsening fatigue despite GLP-1 treatment warrants medical review to investigate other potential causes such as anaemia, thyroid disorders, sleep apnoea, depression, or medication side effects
You should prepare for a substantial expense, as the price for each IV session may start at 5000 or even more in certain locations
4 Concluding remarks, place in therapy, and future perspective Tirzepatide is a novel agent that is approved for the treatment of type 2 diabetes and will likely be approved for weight loss